<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144795">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02146885</url>
  </required_header>
  <id_info>
    <org_study_id>LAMMP-DOS-30139</org_study_id>
    <nct_id>NCT02146885</nct_id>
  </id_info>
  <brief_title>The Use of Diffuse Optical Spectroscopy to Characterizein Response to Weight-Loss Intervention</brief_title>
  <official_title>The Use of Diffuse Optical Spectroscopy to Characterize Adipose Tissue Oxygenation and Vascular Reactivity in Response to Weight-Loss Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montana Compton</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The first step in any clinical intervention against obesity involves sustained lifestyle
      changes. Researcher can use these strategies to beneficial the effects of weight and on
      cardiovascular risk. The researcher develope methods for assessing the effectiveness use
      optical technology to make such assessments, specifically in the area of fatty tissue can
      predict the effectiveness of the intervention in causing weight reduction and treating
      metabolic disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Optical technologies under development at the Beckman Laser Institute.

      Diffuse Optical Spectroscopy Imaging is a method for studying absorption and scattering
      (optical properties) of tissue in humans. It is related to near-infrared spectroscopy , but
      allows for more quantitative and thorough measurements. The researcher use Diffuse Optical
      Spectroscopy to measure fatty tissue, water, blood concentration levael during weight loss
      program to determine the effect of sustained changes in weight or relapses.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Cross-Sectional</study_design>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Preventative Cardiology Program by reduce body weight</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The preventative cardiology program aims to help patients reduce body weight by a significant amount (at least 10%).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>No treatment</arm_group_label>
    <description>Diffuse Optical Spectroscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diffuse Optical Spectroscopy</intervention_name>
    <description>No treatment</description>
    <arm_group_label>No treatment</arm_group_label>
    <other_name>Diffuse Optical Spectroscopy</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        1. Male or female 18 to 65 years of age

          2. Body Mass Index greater than 25 (overweight)

          3. Participation in UCI Weight Loss program (Either Preventative Cardiology, or Weight
             Management Program)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body Mass Index greater than 25 (overweight)

          -  Participation in UCI Weight Loss program (Either Preventative Cardiology, or Weight
             Management Program)

        Exclusion Criteria:

          -  A medical history of myocardial infarction or cerebrovascular stroke

          -  Pregnancy or planned pregnancy during the course of the study period
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shaista Malik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beckman Laser Institute, UCI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beckman Laser Institute</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 20, 2014</lastchanged_date>
  <firstreceived_date>May 19, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Montana Compton</investigator_full_name>
    <investigator_title>Research Nurse Coordinator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Weight Loss</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
